Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TPP-45142-an Anti-HER2 T-cell Engager-Designed for Selective HER2-Low Cancer Immunotherapy.

Molecular cancer therapeutics·2026
Same author

Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.

Blood·2025
Same author

Advancing Target Validation and Ligandability Assessment: Fragment Screening via <sup>19</sup>F NMR Spectroscopy.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Structural insights into epitope-paratope interactions of a monoclonal antibody targeting CEACAM5-expressing tumors.

Nature communications·2024
Same author

Structural and biochemical rationale for Beta variant protein booster vaccine broad cross-neutralization of SARS-CoV-2.

Scientific reports·2024
Same author

Structural and functional basis of inositol hexaphosphate stimulation of NHEJ through stabilization of Ku-XLF interaction.

Nucleic acids research·2023
Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: May 16, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K

Structural Biology for Target Identification and Validation.

Yuliya Dubianok1, Anand Kumar1, Alexey Rak2

  • 1Sanofi R&D, Bio Structure and Biophysics at Integrated Drug Discovery, Vitry-sur-Seine, France.

Methods in Molecular Biology (Clifton, N.J.)
|March 31, 2025
PubMed
Summary
This summary is machine-generated.

Structural biology, using cryo-EM and X-ray crystallography, revolutionizes drug discovery by enabling rational target identification and validation. This structural insight boosts efficiency, reduces costs, and increases the probability of market approval for new drugs.

Keywords:
Artificial intelligence (AI)Cryogenic electron microscopy (cryo-EM)Crystallographic fragment screeningDrug discovery (DD)Fragment-based drug discovery (FBDD)Single particle analysis (SPA)Structural biologyTarget identification and validation (TidVal)X-ray crystallography (X-ray)

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.3K
Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling
10:49

Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling

Published on: September 20, 2016

12.5K

Related Experiment Videos

Last Updated: May 16, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

4.9K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.3K
Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling
10:49

Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling

Published on: September 20, 2016

12.5K

Area of Science:

  • Structural biology
  • Drug discovery
  • Biophysics

Background:

  • Structural biology is transforming drug discovery.
  • Rational approaches are key for target identification and validation.
  • Current methods can be inefficient and costly.

Purpose of the Study:

  • To highlight the impact of structural biology on drug discovery efficiency and success rates.
  • To emphasize the importance of structural insights for target druggability assessment.
  • To advocate for a comprehensive strategy integrating structural information from project inception.

Main Methods:

  • Leveraging structural insights from cryo-electron microscopy (cryo-EM).
  • Utilizing X-ray crystallography for structural determination.
  • Applying these structural data for target identification and validation.

Main Results:

  • Enhanced efficiency in drug discovery projects (time and cost savings).
  • Significantly improved likelihood of achieving market approval.
  • Improved evaluation of target druggability through experimental structural data.

Conclusions:

  • Structural biology provides a rational framework for drug discovery.
  • Experimentally derived structural information is crucial for assessing technical feasibility.
  • Integrating structural insights early enhances the overall drug development process.